Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) Gross margin
Thermo Fisher Scientific Inc.'s gross margin over the twelve months to 30 June 2026 was 40.8%, down 0.1 percentage points from fiscal 2025 (40.9%). Over the past ten years it has ranged from 39.9% (fiscal 2023) to 50.1% (fiscal 2021); the current reading is higher than 18% of that period. That is below the Diagnostics & Research industry median of 50.9% and below the Healthcare sector median of 53.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 40.9% | (0.35) |
| FY2024 | 41.3% | 1.38 |
| FY2023 | 39.9% | (2.34) |
| FY2022 | 42.2% | (7.84) |
| FY2021 | 50.1% | 0.41 |
| FY2020 | 49.7% | 5.32 |
| FY2019 | 44.4% | (0.22) |
| FY2018 | 44.6% | (0.60) |
| FY2017 | 45.2% | (0.64) |
| FY2016 | 45.8% | 0.09 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 40.7% | 0.45 |
| Mar 2026 | 40.3% | (0.77) |
| Dec 2025 | 41.0% | (0.19) |
| Sep 2025 | 41.2% | 0.59 |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 66.4% |
| NTRA Natera, Inc. compare | 65.2% |
| IDXX IDEXX Laboratories, Inc. compare | 62.5% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| DHR Danaher Corporation compare | 58.5% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 50.9% |
| TMO Thermo Fisher Scientific Inc. | 40.8% |
| IQV IQVIA Holdings Inc. compare | 33.0% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.5% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement